Cagent Vascular
Cagent Vascular is leading the way for next generation technology for vessel dilatation with the Serranator PTA Serration Balloon Catheter.
$41M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@CagentVascular · created Mar 23, 2016 (10 years old) · 142 followers
Website registeredMar 20, 2014 (12 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $41M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Similar Health and bio companies
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
PPhrontline Biopharma$40M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cagent-vascular (get a free API key).